MediPharm Touts ‘Transformational Year,’ Posts $22.6M In Q4 Revenue

Cannabis producer MediPharm Labs Corp. (TSX: LABS) (OTC: MEDIF) said Monday that “2019 was a transformational year” for the Ontario, Canada-based company.

“We were one of only a very few cannabis companies to successfully execute on its strategy and be profitable,” MediPharm CEO Pat McCutcheon said in a statement.

MediPharm reported fourth-quarter revenue of CA$32 million ($22.6 million) versus CA$10 million in the corresponding period of 2018.

For the full year, the company posted revenue of CA$129.3 million, gross profit of CA$42.9 million …

Full story available on

More MediPharm Touts 'Transformational Year,' Posts $22.6M In Q4 Revenue